These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30683605)

  • 1. Different Effects of Iron Indices on Mortality in Patients With Autosomal Dominant Polycystic Kidney Disease After Long-Term Hemodialysis: A Nationwide Population-Based Study.
    Yeh SC; Lin YC; Hong YC; Hsu CC; Lin YC; Wu MS
    J Ren Nutr; 2019 Sep; 29(5):444-453. PubMed ID: 30683605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron indices and survival in maintenance hemodialysis patients with and without polycystic kidney disease.
    Hatamizadeh P; Ravel V; Lukowsky LR; Molnar MZ; Moradi H; Harley K; Pahl M; Kovesdy CP; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2013 Nov; 28(11):2889-98. PubMed ID: 24169614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study.
    Ogawa C; Tsuchiya K; Tomosugi N; Kanda F; Maeda K; Maeda T
    PLoS One; 2017; 12(6):e0179608. PubMed ID: 28662118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Anemia and Iron Parameters With Mortality Among Patients Undergoing Prevalent Hemodialysis in Taiwan: The AIM - HD Study.
    Kuo KL; Hung SC; Tseng WC; Tsai MT; Liu JS; Lin MH; Hsu CC; Tarng DC;
    J Am Heart Assoc; 2018 Aug; 7(15):e009206. PubMed ID: 30371224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of serum ferritin and transferrin saturation values associated with two i.v. iron formulations in hemodialysis patients.
    Nguyen TV
    Am J Health Syst Pharm; 2009 Jun; 66(12):1101-4. PubMed ID: 19498125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A; Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Different Association between Serum Ferritin and Mortality in Hemodialysis and Peritoneal Dialysis Patients Using Japanese Nationwide Dialysis Registry.
    Maruyama Y; Yokoyama K; Yokoo T; Shigematsu T; Iseki K; Tsubakihara Y
    PLoS One; 2015; 10(11):e0143430. PubMed ID: 26599216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron, coronary artery calcification, and mortality in patients undergoing hemodialysis.
    Mizuiri S; Nishizawa Y; Doi T; Yamashita K; Shigemoto K; Usui K; Arita M; Naito T; Doi S; Masaki T
    Ren Fail; 2021 Dec; 43(1):371-380. PubMed ID: 33596750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of serum ferritin lead to adequate hemoglobin levels and good survival in hemodialysis patients.
    Ogawa C; Tsuchiya K; Kanda F; Maeda T
    Am J Nephrol; 2014; 40(6):561-70. PubMed ID: 25592750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of anemia and iron parameters with mortality among prevalent peritoneal dialysis patients in Taiwan: the AIM-PD study.
    Kuo KL; Liu JS; Lin MH; Hsu CC; Tarng DC;
    Sci Rep; 2022 Jan; 12(1):1269. PubMed ID: 35075212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Biomarkers of Iron Stores Are Associated with Increased Risk of All-Cause Mortality and Cardiovascular Events in Nondialysis CKD Patients, with or without Anemia.
    Guedes M; Muenz DG; Zee J; Bieber B; Stengel B; Massy ZA; Mansencal N; Wong MMY; Charytan DM; Reichel H; Waechter S; Pisoni RL; Robinson BM; Pecoits-Filho R;
    J Am Soc Nephrol; 2021 Aug; 32(8):2020-2030. PubMed ID: 34244326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low transferrin saturation (TSAT) and high ferritin levels are significant predictors for cerebrovascular and cardiovascular disease and death in maintenance hemodialysis patients.
    Kuragano T; Joki N; Hase H; Kitamura K; Murata T; Fujimoto S; Fukatsu A; Inoue T; Itakura Y; Nakanishi T
    PLoS One; 2020; 15(9):e0236277. PubMed ID: 32877424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease.
    Eisenga MF; Nolte IM; van der Meer P; Bakker SJL; Gaillard CAJM
    BMC Nephrol; 2018 Sep; 19(1):225. PubMed ID: 30208847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive vision for intravenous iron therapy.
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia?
    Kalantar-Zadeh K; Streja E; Miller JE; Nissenson AR
    Adv Chronic Kidney Dis; 2009 Mar; 16(2):143-51. PubMed ID: 19233073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron indices and intravenous ferumoxytol: time to steady-state.
    Kapoian T; O'Mara NB; Carreon M; Gajary A; Rizkala A; Lefavour G; Sherman RA; Walker J
    Ann Pharmacother; 2012 Oct; 46(10):1308-14. PubMed ID: 22968523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESA Hyporesponsiveness Is Associated with Adverse Events in Maintenance Hemodialysis (MHD) Patients, But Not with Iron Storage.
    Kuragano T; Kitamura K; Matsumura O; Matsuda A; Hara T; Kiyomoto H; Murata T; Fujimoto S; Hase H; Joki N; Fukatsu A; Inoue T; Itakura Y; Nakanishi T
    PLoS One; 2016; 11(3):e0147328. PubMed ID: 26933949
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.